58118-0549-8 : NDC 2026 Code

58118-0549-8 : Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate ( Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate )

Additionally :

You can get information about “58118-0549-8” NDC code in 58118-0549-8 in HTML format

HTML | 58118-0549-8 in TXT (Plain Text) format

TXT | 58118-0549-8 in PDF (Portable Document Format)

PDF | 58118-0549-8 in XML format

XML formats.

NDC Code : 58118-0549-8 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "58118-0549-8",
    "PackageDescription": "30 TABLET in 1 BLISTER PACK (58118-0549-8) ",
    "NDC11Code": "58118-0549-08",
    "ProductNDC": "58118-0549",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate",
    "DosageFormName": "TABLET",
    "RouteName": "SUBLINGUAL",
    "StartMarketingDate": "20200901",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA209069",
    "LabelerName": "Clinical Solutions Wholesale, LLC",
    "SubstanceName": "BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE",
    "StrengthNumber": "2; .5",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]",
    "DEASchedule": "CIII",
    "Status": "Active",
    "LastUpdate": "2026-03-06",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260305",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}